Patents by Inventor Kenneth N. Ross

Kenneth N. Ross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prostate cancer diagnosis and outcome prediction by expression analysis
    Patent number: 7501248
    Abstract: Methods identifying prostate cancer, methods for prognosing and diagnosing prostate cancer, methods for identifying a compound that modulates prostate cancer development, methods for determining the efficacy of a prostate cancer therapy, and oligonucleotide microarrays containing probes for genes involved in prostate cancer development are described.
    Type: Grant
    Filed: September 26, 2005
    Date of Patent: March 10, 2009
    Assignees: Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Inc.
    Inventors: Todd R. Golub, Phillip G. Febbo, Kenneth N. Ross, William R. Sellers
  • Prostate cancer diagnosis and outcome prediction by expression analysis
    Patent number: 6949342
    Abstract: Methods identifying prostate cancer, methods for prognosing and diagnosing prostate cancer, methods for identifying a compound that modulates prostate cancer development, methods for determining the efficacy of a prostate cancer therapy, and oligonucleotide microarrays containing probes for genes involved in prostate cancer development are described.
    Type: Grant
    Filed: December 19, 2002
    Date of Patent: September 27, 2005
    Assignees: Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Inc.
    Inventors: Todd R. Golub, Phillip G. Febbo, Kenneth N. Ross, William R. Sellers
  • Prostate cancer diagnosis and outcome prediction by expression analysis
    Publication number: 20030152980
    Abstract: Methods identifying prostate cancer, methods for prognosing and diagnosing prostate cancer, methods for identifying a compound that modulates prostate cancer development, methods for determining the efficacy of a prostate cancer therapy, and oligonucleotide microarrays containing probes for genes involved in prostate cancer development are described.
    Type: Application
    Filed: December 19, 2002
    Publication date: August 14, 2003
    Applicant: Whitehead Institute for Biomedical Research
    Inventors: Todd R. Golub, Phillip G. Febbo, Kenneth N. Ross, William R. Sellers